Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Sardine-enriched Diet for Prevention Type 2 Diabetes in Elderly and Prediabetic Population
| NCT number | NCT03557541 |
| Other study ID # | 2013/8863 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | May 2014 |
| Est. completion date | July 2017 |
| Verified date | July 2018 |
| Source | Institut d'Investigacions Biomèdiques August Pi i Sunyer |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The hypothesis formulated is that 200 g of sardine on a weekly basis will have a favourable impact avoiding the natural development of the pathology due to changes in the biochemical profile, the anthropometrics, inflammatory markers, changes in gut microbiota populations, also in transcriptomics and metabolomics.
| Status | Completed |
| Enrollment | 182 |
| Est. completion date | July 2017 |
| Est. primary completion date | July 2017 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 65 Years and older |
| Eligibility |
Inclusion Criteria: - glycaemia between 100-125 md / dL or =5.7% HbA1c Exclusion Criteria: - treatment with oral antidiabetic drugs - any nutritional education to prevent T2D - Suspect or known hypersensitivity to sardine or related fish - Chronic treatment with oral steroids and / or AINES - Treatment with oral antidiabetic agents and / or insulin - Treatment with immunosuppressive drugs - Diagnosis of active neoplasm - Diagnosis of HIV or AIDS - Abnormal liver profile (> 6 times normal values) - Diagnosis of Acute Psychiatric Sdr - Presence of serious acute concomitant disease, which it requires more than 7 days of recovery. - Major cardiovascular event (stroke, myocardial infarction) in the month prior to randomization. - Any other condition that the investigator considers to be inoperative so that the subject conducts the study. |
| Country | Name | City | State |
|---|---|---|---|
| Spain | Diana A Diaz Rizzolo | Barcelona |
| Lead Sponsor | Collaborator |
|---|---|
| Institut d'Investigacions Biomèdiques August Pi i Sunyer |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | type 2 diabetes new onset | incidence of new diagnosis of type 2 diabetes | Change from Baseline at 12 months | |
| Secondary | adiponectin | adiponectin levels | Change from Baseline at 12 months | |
| Secondary | quantification of gut microbiota populations | quantification by q-PCR | Change from Baseline at 12 months | |
| Secondary | gene expression | relative expression related genes by RT q-PCR (Real Time Quantitative Reverse transcription polymerase chain reaction) | Change from Baseline at 12 months | |
| Secondary | metabolomics study of dietary biomarkers and health biomarkers [(1) Fatty acyls, bile acids, steroids and lysoglycerophospholipids, (2) Glycerolipids, glycerophospholipids, sterol lipids and sphingolipids, (3) Amino acids.] | endogenous metabolic profiles of serum samples will be studied using ultra-high performance liquid chromatography - mass spectrometry (UHPLC-MS). The same unit for measurements [log2 (fold change)] | Change from Baseline at 12 months | |
| Secondary | glucose homeostasis | glucose (mg/dl) | Change from Baseline at 12 months | |
| Secondary | insulin levels | insulin (mU/L) | Change from Baseline at 12 months | |
| Secondary | HOMA-IR (homeostasis model assessment insulin resistance) | insulin resistance index | Change from Baseline at 12 months | |
| Secondary | HOMA-B (homeostasis model assessment B cell function) | B cella function | Change from Baseline at 12 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |